MedPath

Detection of Phrenic Nerve Stimulation Using Sensors' Signals

Completed
Conditions
Heart Failure
Registration Number
NCT01233323
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The purpose of this study is to collect sensor data from patients with implanted cardiac resynchronization devices who exhibit phrenic nerve stimulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Willing and capable of providing informed consent and of participating in all testing
  • Age 18 or above or of legal age to give informed consent specific to national law
  • Implanted with a Boston Scientific COGNIS™ family device
  • Geographically stable and is available for follow-up procedures at a study centre
Exclusion Criteria
  • Patients that are pacemaker-dependent
  • Women who are pregnant or plan to become pregnant during the study (method of assessment upon physician's discretion)
  • Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the patient is participating in a mandatory governmental registry
  • Patients who are not expected to support approximately 30 minutes of study testing procedures
  • Patients who are not mentally competent enough to provide feedback on PS during study procedures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Data collection3 months follow up

Collect sensor data in patients with implanted CRT-D devices who exhibit phrenic nerve stimulation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Deutsches Herzzentrum Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath